These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A clinical evaluation of the prophylactic treatment of poison ivy dermatitis with an alum-precipitated pyridine extract of Rhus toxicodendron. PASSENGER RE. J Allergy; 1963; 34():270-4. PubMed ID: 13941710 [No Abstract] [Full Text] [Related]
4. Poison ivy (Rhus toxicodendron); a survey of the poison ivy problem in Canada and some independent observations on the value of zirconium products in prophylaxis and treatment. CASPERS AP. Can Med Assoc J; 1957 May 15; 76(10):852-60. PubMed ID: 13426931 [No Abstract] [Full Text] [Related]
11. [Rhus dermatitis or poison ivy dermatitis in Lorraine]. Beurey J, Mougeolle JM, Weber M, Mazet J. Ann Dermatol Venereol; 1980 Jan 15; 107(1-2):65-7. PubMed ID: 6445173 [No Abstract] [Full Text] [Related]
12. The treatment of acute poison ivy dermatitis with 3-n-pentadecyl catechol by the intradermal route; a preliminary report. KEIL H. Ann Allergy; 1950 Jan 15; 8(3):356-61. PubMed ID: 15419585 [No Abstract] [Full Text] [Related]
13. Suggestions for management of acute poison ivy dermatitis. HOWELL JB. Tex State J Med; 1949 Jun 15; 45(6):349-53. PubMed ID: 18144363 [No Abstract] [Full Text] [Related]
14. Prophylaxis of Rhus toxicodendron dermatitis. HOAGLAND RJ. N Engl J Med; 1950 Jan 26; 242(4):130-2. PubMed ID: 15408998 [No Abstract] [Full Text] [Related]
15. The effect of hydrous zirconium oxide on Rhus toxicodendron dermatitis; further laboratory experience. CRONK GA, NAUMANN DE. Antibiot Chemother (Northfield); 1955 Feb 26; 5(2):64-6. PubMed ID: 24543391 [No Abstract] [Full Text] [Related]
19. Racial and environmental factors in susceptibility to Rhus. CLAIBORNE ER, EPSTEIN E. AMA Arch Derm; 1957 Feb 26; 75(2):197-201. PubMed ID: 13393788 [No Abstract] [Full Text] [Related]